The 5 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +41.64% increase from the last price of 3.53.
The current consensus among 5 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Nov 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.